Wednesday, September 26, 2012

British Journal of Cancer - Table of Contents alert Volume 107 Issue 7


TABLE OF CONTENTS

Volume 107, Issue 7 (1009-1204)
Published online 25 September 2012

In this issue
Minireviews
Clinical Studies
Translational Therapeutics
Molecular Diagnostics
Epidemiology
Corrigenda

Also new today
Advance online publication

Sign up for e-alerts Sign up for e-alerts
Recommend to your library
Web feed
Subscribe
Advertisement
British Journal of Cancer publishes high quality original papers and reviews that make a significant contribution to increasing understanding of the causes of cancer and to improving the treatment and survival of patients.

Visit the journal online at www.bjcancer.com to view the latest research and access selected articles FREE of charge.
 

Minireviews

Top

Biomarkers: the next therapeutic hurdle in metastatic renal cell carcinoma

G Sonpavde and T K Choueiri

Br J Cancer 2012 107: 1009-1016; advance online publication, September 4, 2012; 10.1038/bjc.2012.399

Abstract | Full Text

Recruitment of ethnic minorities into cancer clinical trials: experience from the front lines

R P Symonds, K Lord, A J Mitchell and D Raghavan

Br J Cancer 2012 107: 1017-1021; advance online publication, May 31, 2012; 10.1038/bjc.2012.240

Abstract | Full Text

Clinical Studies

Top

Phase I oncology trials incorporating patient choice of dose

L W Huson

Br J Cancer 2012 107: 1022-1024; advance online publication, August 28, 2012; 10.1038/bjc.2012.378

Abstract | Full Text

Prediction of early death among patients enrolled in phase I trials: development and validation of a new model based on platelet count and albumin

A Ploquin, D Olmos, D Lacombe, R A'Hern, A Duhamel, C Twelves, S Marsoni, R Morales-Barrera, J-C Soria, J Verweij, E E Voest, P Schöffski, J H Schellens, A Kramar, R S Kristeleit, H-T Arkenau, S B Kaye and N Penel

Br J Cancer 2012 107: 1025-1030; advance online publication, August 21, 2012; 10.1038/bjc.2012.371

Abstract | Full Text

Development of a nomogram incorporating serum C-reactive protein level to predict overall survival of patients with advanced urothelial carcinoma and its evaluation by decision curve analysis

J Ishioka, K Saito, M Sakura, M Yokoyama, Y Matsuoka, N Numao, F Koga, H Masuda, Y Fujii, S Kawakami and K Kihara

Br J Cancer 2012 107: 1031-1036; advance online publication, August 23, 2012; 10.1038/bjc.2012.254

Abstract | Full Text

Oxaliplatin/capecitabine vs oxaliplatin/infusional 5-FU in advanced colorectal cancer: the MRC COIN trial

A Madi, D Fisher, R H Wilson, R A Adams, A M Meade, S L Kenny, L L Nichols, M T Seymour, H Wasan, R Kaplan and T S Maughan on behalf of the COIN trial research group

Br J Cancer 2012 107: 1037-1043; advance online publication, August 30, 2012; 10.1038/bjc.2012.384

Abstract | Full Text

Vascular density analysis in colorectal cancer patients treated with vatalanib (PTK787/ZK222584) in the randomised CONFIRM trials

A Giatromanolaki, M I Koukourakis, E Sivridis, K C Gatter, T Trarbach, G Folprecht, M M Shi, D Lebwohl, T Jalava, D Laurent, G Meinhardt and A L Harris for the ‘Tumour and Angiogenesis Research Group’

Br J Cancer 2012 107: 1044-1050; advance online publication, August 21, 2012; 10.1038/bjc.2012.369

Abstract | Full Text

Face-to-face vs telephone pre-colonoscopy consultation in colorectal cancer screening; a randomised trial

E M Stoop, T R de Wijkerslooth, P M Bossuyt, J Stoker, P Fockens, E J Kuipers, E Dekker and M E van Leerdam

Br J Cancer 2012 107: 1051-1058; advance online publication, August 23, 2012; 10.1038/bjc.2012.358

Abstract | Full Text

Association between treatment effects on disease progression end points and overall survival in clinical studies of patients with metastatic renal cell carcinoma

T E Delea, A Khuu, D YC Heng, T Haas and D Soulières

Br J Cancer 2012 107: 1059-1068; advance online publication, August 30, 2012; 10.1038/bjc.2012.367

Abstract | Full Text

Does tumour biology determine surgical success in the treatment of epithelial ovarian cancer? A systematic literature review

J Borley, C Wilhelm-Benartzi, R Brown and S Ghaem-Maghami

Br J Cancer 2012 107: 1069-1074; advance online publication, August 30, 2012; 10.1038/bjc.2012.376

Abstract | Full Text

Brain metastases in Asian HER2-positive breast cancer patients: anti-HER2 treatments and their impact on survival

Y S Yap, G H Cornelio, B C R Devi, C Khorprasert, S B Kim, T Y Kim, S C Lee, Y H Park, J H Sohn, N Sutandyo, D W Y Wong, M Kobayashi, S H Landis, E M Yeoh, H Moon and J Ro

Br J Cancer 2012 107: 1075-1082; advance online publication, August 23, 2012; 10.1038/bjc.2012.346

Abstract | Full Text

Translational Therapeutics

Top

Curcumin–cyclodextrin complexes potentiate gemcitabine effects in an orthotopic mouse model of lung cancer

N Rocks, S Bekaert, I Coia, G Paulissen, M Gueders, B Evrard, J-C Van Heugen, P Chiap, J-M Foidart, A Noel and D Cataldo

Br J Cancer 2012 107: 1083-1092; advance online publication, August 28, 2012; 10.1038/bjc.2012.379

Abstract | Full Text

Safety, tolerability, pharmacokinetics and pharmacodynamics of AZD8055 in advanced solid tumours and lymphoma

A Naing, C Aghajanian, E Raymond, D Olmos, G Schwartz, E Oelmann, L Grinsted, W Burke, R Taylor, S Kaye, R Kurzrock and U Banerji

Br J Cancer 2012 107: 1093-1099; advance online publication, August 30, 2012; 10.1038/bjc.2012.368

Abstract | Full Text

Dose banding as an alternative to body surface area-based dosing of chemotherapeutic agents

E Chatelut, M L White-Koning, R HJ Mathijssen, F Puisset, S D Baker and A Sparreboom

Br J Cancer 2012 107: 1100-1106; advance online publication, August 28, 2012; 10.1038/bjc.2012.357

Abstract | Full Text

Post-chemotherapy T-cell recovery is a marker of improved survival in patients with advanced thoracic malignancies

M J McCoy, R A Lake, R G van der Most, I M Dick and A K Nowak

Br J Cancer 2012 107: 1107-1115; advance online publication, August 21, 2012; 10.1038/bjc.2012.362

Abstract | Full Text

Epigenetic remodelling of gene expression profiles of neoplastic and normal tissues: immunotherapeutic implications

S Coral, A Covre, H JMG Nicolay, G Parisi, A Rizzo, F Colizzi, S Dalla Santa, E Fonsatti, E Fratta, L Sigalotti and M Maio

Br J Cancer 2012 107: 1116-1124; advance online publication, August 21, 2012; 10.1038/bjc.2012.361

Abstract | Full Text

Molecular Diagnostics

Top

Tissue factor expression in the metaplasia–adenoma–carcinoma sequence of gastric cancer in a European population

L Lo, H Valentine, J Harrison, S Hayes, I Welch, S Pritchard, C West and Y Ang

Br J Cancer 2012 107: 1125-1130; advance online publication, August 28, 2012; 10.1038/bjc.2012.363

Abstract | Full Text

Prognostic utility of pre-operative circulating osteopontin, carbonic anhydrase IX and CRP in renal cell carcinoma

S H Sim, M P Messenger, W M Gregory, T C Wind, N S Vasudev, J Cartledge, D Thompson, P J Selby and R E Banks

Br J Cancer 2012 107: 1131-1137; advance online publication, August 23, 2012; 10.1038/bjc.2012.360

Abstract | Full Text

The utility of molecular diagnostics to predict recurrence of head and neck carcinoma

C Pena Murillo, X Huang, A Hills, M McGurk, A Lyons, J-P Jeannon, E Odell, A Brown, K Lavery, W Barrett, M Sherriff, R Brakenhoff and M Partridge

Br J Cancer 2012 107: 1138-1143; advance online publication, August 23, 2012; 10.1038/bjc.2012.213

Abstract | Full Text

WNT/β-catenin pathway activation in Myc immortalised cerebellar progenitor cells inhibits neuronal differentiation and generates tumours resembling medulloblastoma

H A Rogers, S Sousa, C Salto, E Arenas, B Coyle and R G Grundy

Br J Cancer 2012 107: 1144-1152; advance online publication, August 28, 2012; 10.1038/bjc.2012.377

Abstract | Full Text

Tumour basement membrane laminin expression predicts outcome following curative resection of pancreatic head cancer

J A van der Zee, C HJ van Eijck, W CJ Hop, K Biermann, B M Dicheva, A LB Seynhaeve, G A Koning, A MM Eggermont and T LM ten Hagen

Br J Cancer 2012 107: 1153-1158; advance online publication, August 28, 2012; 10.1038/bjc.2012.373

Abstract | Full Text

Epidemiology

Top

Effects of changes in diagnosis and registration on time trends in recorded childhood cancer incidence in Great Britain

M E Kroll, L M Carpenter, M F G Murphy and C A Stiller

Br J Cancer 2012 107: 1159-1162; advance online publication, August 16, 2012; 10.1038/bjc.2012.296

Abstract | Full Text

An examination, with a meta-analysis, of studies of childhood leukaemia in relation to population mixing

L J Kinlen

Br J Cancer 2012 107: 1163-1168; advance online publication, September 6, 2012; 10.1038/bjc.2012.402

Abstract | Full Text

The prognostic importance of miR-21 in stage II colon cancer: a population-based study

S Kjaer-Frifeldt, T F Hansen, B S Nielsen, S Joergensen, J Lindebjerg, F B Soerensen, R dePont Christensen and A Jakobsen

Br J Cancer 2012 107: 1169-1174; 10.1038/bjc.2012.365

Abstract | Full Text

Are lower rates of surgery amongst older women with breast cancer in the UK explained by co-morbidity?

K Lavelle, A Downing, J Thomas, G Lawrence, D Forman and S E Oliver

Br J Cancer 2012 107: 1175-1180; advance online publication, August 9, 2012; 10.1038/bjc.2012.192

Abstract | Full Text

Ovarian cancer and menopausal hormone therapy in the NIH-AARP diet and health study

B Trabert, N Wentzensen, H P Yang, M E Sherman, A Hollenbeck, K N Danforth, Y Park and L A Brinton

Br J Cancer 2012 107: 1181-1187; advance online publication, August 28, 2012; 10.1038/bjc.2012.397

Abstract | Full Text

Quantitative relationship between silica exposure and lung cancer mortality in German uranium miners, 1946–2003

M Sogl, D Taeger, D Pallapies, T Brüning, F Dufey, M Schnelzer, K Straif, L Walsh and M Kreuzer

Br J Cancer 2012 107: 1188-1194; advance online publication, August 28, 2012; 10.1038/bjc.2012.374

Abstract | Full Text

Projections of cancer prevalence in the United Kingdom, 2010–2040

J Maddams, M Utley and H Møller

Br J Cancer 2012 107: 1195-1202; advance online publication, August 14, 2012; 10.1038/bjc.2012.366

Abstract | Full Text

Corrigenda

Top

MicroRNA-204 increases sensitivity of neuroblastoma cells to cisplatin and is associated with a favourable clinical outcome

J Ryan, A Tivnan, J Fay, K Bryan, M Meehan, L Creevey, J Lynch, I M Bray, A O'Meara, L Tracey, A M Davidoff and R L Stallings

Br J Cancer 2012 107: 1203; 10.1038/bjc.2012.425

Full Text

Diagnostic radiography and adult acute myeloid leukemia: an interview and medical chart review study

J M Pogoda, P W Nichols, R K Ross, D O Stram, D C Thomas and S Preston-Martin

Br J Cancer 2012 107: 1204; 10.1038/bjc.2012.426

Full Text

Advertisement
Ensure your access to British Journal of Cancer

If you are unable to access the articles in this Table of Contents e-alert, your library may not subscribe to this journal. Our online recommendation form is a simple way to make your librarian aware that this journal is valuable to your research.

Recommend now at http://www.nature.com/librec/svc/request/makeCommRequest?id=2.
 

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to British Journal of Cancer. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA

Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS.

© 2012 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.

nature publishing group
 

No comments: